96 related articles for article (PubMed ID: 6861159)
1. Depression of high-affinity rosette formation in dysplasia and carcinoma in situ of the uterine cervix: mediation by serum factors.
Bashford J; Gough IR
Cancer Res; 1983 Aug; 43(8):3959-62. PubMed ID: 6861159
[TBL] [Abstract][Full Text] [Related]
2. High-affinity erythrocyte rosette formation and inhibition in premalignant disease of the uterine cervix.
Bashford J; Gough IR
Cancer Res; 1983 Aug; 43(8):3955-8. PubMed ID: 6861158
[TBL] [Abstract][Full Text] [Related]
3. Rosette formation and inhibition in cervical dysplasia and carcinoma in situ.
Sawanobori S; Ashman RB; Nahmias AJ; Benigno BB; LaVia MF
Cancer Res; 1977 Dec; 37(12):4332-5. PubMed ID: 922724
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
Dini MM; Jafari K; Faiferman I
Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
[TBL] [Abstract][Full Text] [Related]
5. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
Ishiguro T
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426
[TBL] [Abstract][Full Text] [Related]
6. Stereologic estimation of the total numbers, the composition and the anatomic distribution of lymphocytes in cone biopsies from patients with stage I squamous cell carcinoma of the cervix uteri.
Nedergaard BS; Nielsen K; Nyengaard JR; Ladekarl M
APMIS; 2007 Dec; 115(12):1321-30. PubMed ID: 18184401
[TBL] [Abstract][Full Text] [Related]
7. A study of humoral factors in carcinoma cervix.
Agarwal J; Gupta SC; Singh PA; Bisht D; Keswani NK
Indian J Pathol Microbiol; 1992 Jan; 35(1):5-10. PubMed ID: 1452247
[TBL] [Abstract][Full Text] [Related]
8. A, B & H isoantigens in cervical lesions.
Bisht D; Misra V; Gupta SC; Mehrotra R; Garg S
Indian J Pathol Microbiol; 1998 Jan; 41(1):11-4. PubMed ID: 9581070
[TBL] [Abstract][Full Text] [Related]
9. [Functional indices of the peripheral blood lymphocytes in gynecologic patients].
Stepankovskaia GK; Senchuk AIa; Iarotskiĭ NE
Vrach Delo; 1989 Oct; (10):81-3. PubMed ID: 2617996
[TBL] [Abstract][Full Text] [Related]
10. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
11. EA-rosette test in cervical cell suspensions.
Noltenius H; Bergmann R
Anal Quant Cytol; 1981 Dec; 3(4):281-8. PubMed ID: 7332156
[TBL] [Abstract][Full Text] [Related]
12. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
13. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
Khaled A; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
[TBL] [Abstract][Full Text] [Related]
16. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
Micke O; Bruns F; Schäfer U; Prott FJ; Willich N
Anticancer Res; 2005; 25(3A):1663-6. PubMed ID: 16033078
[TBL] [Abstract][Full Text] [Related]
17. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.
Sonoda K; Kaku T; Kamura T; Nakashima M; Watanabe T; Nakano H
Clin Cancer Res; 1998 Jun; 4(6):1517-20. PubMed ID: 9626471
[TBL] [Abstract][Full Text] [Related]
19. ["In vivo" and "in vitro" immunological monitoring in carcinoma of the uterine cervix].
Sacco F; Benedetti Panici P; Di Roberto P; Margariti PA; Villani L; Laghi V; Cauda R; Nervo P
Minerva Ginecol; 1982 Apr; 34(4):259-64. PubMed ID: 7048137
[No Abstract] [Full Text] [Related]
20. Decreased amniotic fluid peroxidase in malignancy of the cervix.
Armstrong D; Van Wormer D; Dimmitt S
Cancer Biochem Biophys; 1977; 2(1):1-4. PubMed ID: 616316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
